Former GlaxoSmithKline CEO Andrew Witty takes the helm at UnitedHealth; After more than a decade, Daniel Chung is back on a familiar project
After reportedly hinting that he was considering leaving the helm of UnitedHealth Group’s Optum unit, Sir Andrew Witty has landed a big promotion.
The former GlaxoSmithKline CEO is stepping up as UnitedHealth’s next CEO, taking the place of David Wichmann, who recently announced his retirement after spending less than four years in the role.
The move comes a few months after Witty returned from an unpaid leave to help the World Health Organization’s vaccine effort, according to the company. The promotion is effective immediately, though Wichmann will stay on board through March to help with the transition.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 154,000+ biopharma pros reading Endpoints daily — and it's free.